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Abstract
Purpose The present study was performed to get a better
insight in the incidence of anastomotic leakage leading to
reintervention when using the C-seal: a biodegradable
sheath that protects the stapled colorectal anastomosis from
leakage.
Methods The C-seal is a thin walled tube-like sheath that
forms a protective sheath within the bowel lumen. Thirty-
seven patients undergoing surgery with creation of a stapled
colorectal anastomosis with C-seal were analyzed. Follow-
up was completed until 3 months after surgery.
Results One patient (3 %) developed anastomotic leakage
leading to reintervention. None of the 37 anastomoses was
dismantled. One patient was diagnosed with a rectovaginal
fistula. In three patients (8 %), a perianastomotic abscess
spontaneously drained.
Conclusion The incidence of anastomotic leakage leading
to reintervention when using the C-seal (3 %) is lower than
expected based on the literature (11 %). We have currently
set-up a multicenter randomized trial to confirm the efficien-
cy of the C-seal (www.csealtrial.nl).
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Purpose
Anastomotic leakage is a major complication of a low anterior
resection. Anastomotic leakage may lead to prolonged hospi-
tal stay, reintervention, sepsis, and even death [1–6]. Besides a
very complicated postoperative recovery, anastomotic leakage
can have lifelong impact, with a high risk of a permanent
stoma and increased risk of fecal incontinence [7–10]. The
current incidence of anastomotic leakage of colorectal anas-
tomoses is reported to be approximately 11 % [1–5].
To prevent clinical consequences of anastomotic leakage,
a defunctioning stoma during the initial operation may be
created [6]. A stoma, however, also has its drawbacks: it is
cumbersome for the patient, complications associated with
the stoma can occur, and a second intervention is needed for
stoma reversal [9]. Moreover, in 8–20 % of patients, the
stoma is never reversed [10, 11].
In the past years, we have developed a device which we
called the “C-seal”. The C-seal is a biodegradable soft sheath
that protects the stapled colorectal anastomosis from leakage
[12–14]. In case of ischaemia or technical error, it might not
prevent the formation of dehiscence of the anastomotic walls,
but it will prevent leakage of fecal content from the lumen of
the intestine into the abdominal cavity or towards the retro-
peritoneal space. Also, if the anastomotic dehiscence is small
or distal from the level of the anastomosis and covered by the
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C-seal, the defect may heal without interventions by second-
ary intent.
Previously, we performed a feasibility study applying the
C-seal successfully [12].
In this report, we have further evaluated the inci-
dence of anastomotic leakage when using the C-seal in
a phase II study.
Methods
The study was approved by the medical ethics committees
of the participating hospitals and by the Dutch Health Care
Inspectorate and performed in accordance with the ethical
standards of the Helsinki Declaration.
Study population
To be eligible, patients were electively planned for colorec-
tal resection with the creation of a stapled anastomosis at
maximally 15 cm from the anal verge. Inclusion criteria
further included age ≥18 years and ASA score ≤3. Patients
with an active inflammation at the time of surgery and
patients who were treated in an acute setting were excluded.
All consecutive patients were asked to participate, and in-
formed consent was obtained after at least 1 week of reflec-
tion. All patient data were anonymised.
Endpoints
The primary endpoint of this study was anastomotic leakage
leading to reintervention. Reintervention was defined as
relaparotomy with either dismantling of the anastomosis
and creation of an end-colostomy, placement of drains in
the pelvis, creation of a diverting stoma, or drainage (radio-
logical guided) of a pelvic abscess.
Secondary endpoints included the assessment of technical
feasibility of applying the C-seal and successful clearance
(biofragmentation) of the C-seal. Procedure or device related
serious and nonserious adverse events during the application
and during the postoperative period were registered.
The C-seal
The C-seal is made from biodegradable polyurethane, com-
posed of “hard” and “soft”molecular components. The “hard”
component provides the desired elastic and mechanical prop-
erties and consists of polyurethane bindings (HNCO2) com-
posed of a di-isocyanate (OCN-NCO) and a diol (HO-OH).
The “soft” segment has a hydrophilic character and deter-
mines the degradation behavior of the polyurethane.
The C-seal is compatible with all circular staplers currently
used for colorectal anastomoses. The staplers used in this
study were the Ethicon Endo-Surgery Circular Staplers (29
or 33 mm diameter) (Ethicon Endo-Surgery, Johnson & John-
son Medical BV, Amersfoort, the Netherlands) and Covidien
Premium Plus CEEA (28 or 31 mm head diameter) (Covidien
Nederland BV, Zaltbommel, the Netherlands).
The application of the C-seal has been described else-
where [15, 16]. Briefly, the C-seal is attached to the anvil of
the circular stapler as illustrated in Figs. 1 and 2. Applica-
tion of the C-seal has been slightly altered since its intro-
duction [14, 17]. The C-seal is attached to the stapler with
sided tape (3 M Hi Tack conformable double-coated tape
#1510) instead of glue, and a marble is inserted in the seal to
facilitate placement of the C-seal in the proximal bowel loop
and to check its position in the bowel.
The anvil together with the attached C-seal is introduced in
the proximal bowel loop. The circular stapler is introduced in
the rectal stump, connected to the anvil, and fired. In this way,
the C-seal is attached to the staplers just proximal of the
anastomosis. By pulling the stapler with the C-seal through
the anus, the C-seal forms a protective sheath covering the
anastomosis starting just proximal to the stapled intestinal
walls. The C-seal is cut from the stapler/anvil and shortened
at an adequate distance (4 cm) from the anal verge (Fig. 3).
The C-seal remains in situ for at least 1 week; the exact
duration to completely dissolve depends on the humidity.
Follow-up
Patients received standard postoperative care according to
local protocol. One week after the operation, a rectal con-
trast enema was performed to check for anastomotic leak-
age. Water-soluble contrast was first syringed within the
lumen of the C-seal and next in the lumen between the C-
seal and the rectum mucosa. Anastomoses within 4 cm of
the anal verge were only syringed within the C-seal to
prevent manipulation of the anastomosis. A case report form
was kept and completed by the attending physician. Serious
adverse events had to be reported within 24 h to the study
coordinator. After hospital discharge, patients were evaluat-
ed at the outpatient clinic. Patients were followed until
3 months postoperatively.
Results
Between January 2010 and October 2010, 37 patients were
included in one of the following hospitals: University Medical
Center Groningen (n=16), Medical Center Leeuwarden
(n=6), Laurentius Hospital Roermond (n=4), Ommelander
Hospital Group (in Delfzijl and Winschoten, n=5), Wilhelmi-
naHospital Assen (n=3), andAntonius Hospital Sneek (n=3).
Patients were operated for malignancy (n=30), divertic-
ulosis (n=5), endometriosis (n=1), and a rectovaginal
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fistula (n=1). The median age was 65 years (range 27–
79). Baseline characteristics are listed in Table 1.
Endpoints
Anastomotic leakage leading to reintervention
One anastomotic leakage (3 %) leading to reintervention
occurred in a patient who underwent rectal resection en bloc
with part of the posterior vaginal wall because of endome-
triosis located in the rectovaginal septum. The colorectal
anastomosis was created at 4 cm distance from the anal
verge. On postoperative day 16, this patient was readmitted
to hospital with a vaginal bleeding originating from the
pudendal artery. This artery was coiled, a loop ileostomy
was created, and debridement of the inflammatory mass
between rectum and vagina was performed. The anastomot-
ic leakage from the rectum to the posterior vaginal wall had
probably caused inflammation of the surrounding tissue
resulting in a rectovaginal fistula and bleeding. The anasto-
mosis was kept intact and maintained. The fistula healed by
secondary intention, and after 3 months, the stoma was
successfully taken down.
Fig. 1 The C-seal is attached to the anvil of the circular stapler
Fig. 2 The C-seal attached to the anvil of the circular stapler Fig. 3 Creation of the anastomosis with the C-seal
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Anastomotic leakage not leading to reintervention
A female patient, treated for rectal cancer with a low anterior
resection with deviating ileostomy (anastomosis at 3 cm
from the anal verge), presented with abdominal pain and
pus per vaginum 15 days after surgery. Vaginal and rectal
examination revealed a rectovaginal fistula: the posterior
vaginal wall was apparently stapled together with the anas-
tomosis. This patient was initially treated conservatively.
Since this fistula persisted, closure was attempted 8 months
after the primary low anterior resection.
In three patients (8 %), rectal pus discharge occurred, which
was interpreted as a perianastomotic abscess (CT proven in one
of these three patients). One of these patients was initially
treated for a fistula after previous low anterior resection for
rectal cancer, and the other two underwent low anterior resec-
tion for rectal cancer. All three had a diverting ileostomy, and
the anastomosis was situated at, respectively, 2, 6, and 6 cm
from the anal verge. Another two patients (5 %) treated for
rectal cancer with a low anterior resection (anastomosis at 4 and
7 cm; one with a diverting stoma) had a CT-proven presacral
infiltration and were antibiotically treated. All recovered well,
and none of these patients had a reintervention.
Clearly, patients with rectal cancer undergoing low anterior
resection have a higher chance of developing anastomotic
leakage compared to patients undergoing anterior resection
for sigmoid pathologies with the anastomosis situated at greater
distance from the anal verge. In our group, 28 patients underwent
a low anterior resection for rectal cancer, and 7 patients
underwent surgery for sigmoid pathologies (5 for diverticulosis
and 2 for cancer). In this “sigmoid” subgroup, the anastomosis
was situated between 10 and 15 cm above the anal verge, and
none had an anastomotic related complication. Only one of the
patients in this “sigmoid” group received a diverting stoma.
All anastomosis-related complications occurred in pa-
tients with the anastomosis situated within 8 cm distance
from the anal verge.
Secondary endpoints
Application of the C-seal
The C-seal was successfully applied without any complica-
tions in 35 patients. The extra time needed by the surgeon to
apply the C-seal was on average 5 min.
In two cases (5 %), it was impossible to pull the C-seal
through the anus after firing the stapler. It appeared that the
C-seal was double-stapled at the anastomotic site after in-
terposition of the “tail” of the C-seal due to inadequate
positioning of this “tail” in the afferent loop. To solve this
problem, the C-seal was cut transanally, which prevented
any obstruction. Both patients are included in the analysis
according to the intention to treat principle and had an
uneventful recovery.
Upon survey of applicability, 65 % of the surgeons rated
the use of the C-seal as “good” on a five-point scale ranging
from excellent–good–average–fair to poor. Another 34 % rat-
ed the procedure as “average”. Upon feedback, it appeared
that initially the insertion of the anvil with the attached C-seal
into the proximal bowel loop was found to be cumbersome.
Rectal contrast enemas were performed on postoperative
day 7 (range day 6–10). Contrast was inserted within the
lumen of the C-seal as well as in the space between the C-
seal and the rectum mucosa, so that leaks above and below
the anastomosis will be demonstrated. In four patients, the
enema was not performed because of logistic reasons. In
five patients, the rectal contrast enemas demonstrated leak-
age of contrast outside the bowel contour. Among these five
patients are the patient with anastomotic leakage leading to
reintervention, the patient with the rectovaginal fistula, and
a patient with a spontaneously drained abscess at the anas-
tomosis as mentioned above. The two remaining patients
with a radiological leakage had no clinical signs or compli-
cations of anastomotic leakage.
Clearance of the C-seal
The C-seal cleared from the bowel after a median of 14 days
(range 5–63 days). In patients without a diverting stoma,
Table 1 Characteristics of 37 patients treated with the C-seal
N=37
Median age in years (range) 65 (27–79)
Male 22 (59 %)
Indication
Carcinoma 30 (81 %)
Diverticular disease 5 (14 %)
Endometriosis 1 (3 %)
Fistula 1 (3 %)
ASA-score
I 12 (32 %)
II 18 (49 %)
III 7 (19 %)
Radiation therapy
Not performed 10 (27 %)
Yes (either5x5 Gy, 25x2 Gy, or 28x1.8 Gy) 27 (73 %)
Median distance of anastomosis to anal
verge in cm (range)
6 (2–15)
Creation of diverting stoma
Yes 18 (49 %)
No 19 (51 %)
ASA-score American society of anaesthesiologists score
I a normal healthy patient, II a patient with mild systemic disease, and
III a patient with severe systemic disease
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median time to losing the C-seal was 10 days. In patients
with a diverting stoma, the exact time of C-seal disappear-
ance is not always known, since the C-seal fragments and
resolves in the bowel lumen and becomes unrecognizable as
such. In one patient with a diverting loop ileostomy, the
anastomosis was checked by proctoscopy at 63 days after
surgery (according to local hospital protocol), and a part of
the C-seal was still visible at the anastomotic site.
Reinterventions not related to the C-seal
One patient (3 %) underwent surgical intervention in the
postoperative phase for stoma retraction. This was not relat-
ed to the C-seal, nor did this patient suffer from anastomotic
leakage.
Perioperative mortality
One patient (3 %) died because of a pulmonary embolism
and myocardial infarction 10 days after surgery. No signs of
anastomotic leakage or adverse events due to the C-seal
were suspected at clinical and laboratory evaluation.
Discussion
The C-seal is a biodegradable soft sheath that covers the
colorectal anastomosis and aims to prevent anastomotic
leakage and clinical consequences. This study evaluates
the incidence of anastomotic leakage leading to complica-
tions and reintervention in patients treated with the C-seal.
We hypothesized that the C-seal prevents extravasation
of feces in case of an anastomotic dehiscence and allows
healing by secondary intent. The anastomotic leakage rate
leading to reintervention of 3 % when using the C-seal is
lower than the 11 % leakage as reported in current
literature[1–5], suggesting a protective effect of the C-seal
on anastomotic leakage.
Five patients were diagnosed with a perianastomotic ab-
scess or infiltration. Clearly, a perianastomotic abscess should
be considered as anastomotic leakage [18]. From the litera-
ture, the incidence of contained leaks (perianastomotic ab-
scesses or infiltration) is up to 50 % of diagnosed leakages
[15–17, 19]. The discrepancy between our findings and the
literature might be explained by a migration of the degree of
severity of anastomotic leakage: with C-seal, a lower percent-
age of full blown anastomotic leakages and a higher percent-
age of “contained leakagese” may occur.
We found a radiologic anastomotic leakage in five patients
(14 %), with one patient developing anastomotic leakage
leading to reintervention. As described in the literature, our
radiologic anastomotic leakage incidence is higher than the
incidence of clinical anastomotic leakage [20].
In 49 % of our patients, the anastomosis was protected by
a deviating stoma. Although a deviating stoma does not
prevent anastomotic leakage to occur, many surgeons be-
lieve it reduces the consequences of anastomotic leakage. In
this study, deviating stomas were created at the discretion of
the operating surgeon. We encouraged participating surgeons
to take the decision of a stoma or not without considering a
possible benefit of the C-seal. In the literature, Matthiessen et
al. randomized patients who underwent a low stapled colorec-
tal anastomosis to a deviating stoma or not [6]. In the group of
patients with a stoma, anastomotic leakage occurred in 12 of
116 patients (10 %); and in the group without a stoma,
anastomotic leakage occurred in 33 of 118 (28 %). Data from
the Dutch Surgical Colorectal Audit reveal that in the period
2009–2011, 3,313 patients with a colorectal anastomosis were
registered. A deviating stoma was created in 2,190 patients
(66 %) [18]. anastomotic leakage occurred in 10 % of patients
with a deviating stoma and in 13 % of the patients without a
deviating stoma [5]. With a 10 % anastomotic leakage per-
centage in the presence of a deviating stoma, we consider the
use of the C-seal to remain beneficial.
Time to degradation of the C-seal depends on the humid-
ity of the environment. In our series, we observed a patient
with a deviating stoma, where parts of the C-seal were still
present in the bowel lumen at 63 days after the operation.
We believe that such a late degradation is not harmful, as
eventually the C-seal will be cleared from the bowel lumen.
The C-seal can give some inconvenience of hygienic
nature, since cleaning the sheath can be difficult. Further-
more, as the C-seal crosses the anal sphincter, soiling may
occur. This discomfort is temporary, since the C-seal is
cleared from the bowel lumen or is cut at the anal verge at
time of discharge from the hospital.
The C-seal can be applied in both open and laparoscopic
techniques, as long as the colorectal anastomosis is created
by a circular stapler. In laparoscopic surgery, a skin incision
is usually made to introduce the anvil in the proximal bowel
loop. The proximal bowel loop should slightly protrude above
skin level to facilitate insertion of the anvil with the attached
C-seal. The procedure remains essentially unchanged. In this
study, in 14 (38 %) patients, a laparoscopic procedure was
performed, of which a conversion was necessary in three
patients. No indication for conversion was related to use of
the C-seal.
All outcome parameters monitored in the phase II study
had also been prospectively documented in our C-seal fea-
sibility study that was performed immediately prior to this
consecutive series. Therefore, we were able to merge the
study results to determine the overall incidence of anasto-
motic leakage leading to reintervention. Thus, in total, fifty-
two patients have now been treated with the C-seal. The
results are promising, with an anastomotic leakage leading
to reintervention rate of 2 %. We have currently set-up a
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multicenter, randomized, open phase III trial in patients
undergoing surgery with creation of a stapled anastomosis
to confirm the efficiency of the C-seal in preventing anas-
tomotic leakage leading to reintervention (csealtrial.nl).
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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